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Introduction
Deinococcus radiodurans (DEIRA) is an aerobic, non-pathogenic, red-pigmented Gram-positive bacterium that exhibits significant resistance to ionizing and ultraviolet radiation, desiccation and the presence of reactive oxygen species (ROS; Minton, 1994; Mattimore & Battista, 1996; Battista, 1997) . The capability of DEIRA to withstand acute radiation doses of up to 1500 krad is intriguing and the bacterium has been the subject of intensive investigation in order to try to understand how this is possible. Exposure to such high doses of ionizing radiation causes massive damage to genomic DNA and a phenomenal capability of DEIRA to repair such damage, perhaps aided by a unique packaging of DNA in its cells, is thought to be responsible for the bacterium's ability to recover its viability (Minton, 1994; Makarova et al., 2001; Levin-Zaidman et al., 2003) . However, it should be noted that the damaging effects of ionizing radiation are enhanced in the presence of oxygen, as ROS such as the hydroxyl radical (OH Á ), the superoxide radical (O À 2 ), hydrogen peroxide (H 2 O 2 ) and organic hydroperoxides which can also cause damage to cellular material are produced (Misra & Fridovich, 1976) . Limiting the damage caused to DNA by ROS must therefore also be important to the ability of DEIRA to withstand the toxic effects of ionizing radiation.
As part of a structural genomics project focusing on the determination of the three-dimensional structures of gene products that may be important in contributing to the extremophile nature of DEIRA strain R1, we have targeted a number of enzymes involved in the neutralization of ROS. One such enzyme is the manganesedependent superoxide dismutase (Mn-SOD; DR1279; EC 1.15.11), which catalyses the disproportionation of superoxide radicals to oxygen and hydrogen peroxide (Fridovitch, 1986) .
At first sight, Mn-SOD from DEIRA might seem to be a strange choice of target. After all, the three-dimensional structures and reaction mechanisms of Mn-SODs from other organisms (including that from Escherichia coli) have been extensively studied and characterized (Borgstahl et al., 2000; Edwards et al., 2001 and references therein) . The amino-acid sequence of DEIRA Mn-SOD has (apart from a six-residue insert between residues 91 and 92) 57% identity ( Fig. 1 ) with its homologue from E. coli and therefore its threedimensional structure and mechanism of action must be very similar to those of E. coli Mn-SOD. However, Mn-SOD is highly (Chou & Tan, 1990 ) and apparently constitutively (Lipton et al., 2002) expressed by DEIRA and DEIRA mutants lacking Mn-SOD are much more sensitive to the effects of ionizing radiation than are both wild-type DEIRA or DEIRA mutants that do not express the catalase KatA (Markillie et al., 1999) . This suggests that the neutralization of superoxide radicals is more important to the extremophile nature of DEIRA than the neutralization of hydrogen peroxide. Investigations of the structure of DEIRA Mn-SOD may provide structural reasons for the importance of Mn-SOD to the survival of DEIRA. We therefore now report the three-dimensional structure of Mn-SOD from DEIRA (Mn-SOD Dr ) in two different crystal forms as determined using single-crystal X-ray diffraction techniques and, in particular, compare them with the crystal structure of the Mn-SOD from E. coli (Mn-SOD Ec ; PDB code 1vew; Edwards et al., 1998) .
Materials and methods

Protein cloning, expression and purification
The Mn-SOD gene from D. radiodurans (DR1279) was amplified by Pfu DNA polymerase, subcloned into a Gateway pDest17 vector (Invitrogen) containing a 2.6 kDa N-terminal fusion tag that includes a hexahistidine region and transformed into BL21(DE3)pLysS E. coli cells (Novagen). One colony of bacteria was used to inoculate 10 ml of Luria-Bertani (LB) broth to which ampicillin (50 mg ml À1 ) and chloramphenicol (34 mg ml À1 ) had been added. An overnight culture was then grown at 310 K, shaking the flasks at $200 rev min À1 . This was then centrifuged at 1500g for 10 min with the resulting pellet being resuspended in 10 ml 2ÂYT medium and used to inoculate 500 ml 2ÂYT medium supplemented with ampicillin (100 mg ml À1 ) and chloramphenicol (34 mg ml À1 ). This was incubated at 295 K until the cell density reached an OD 600 of $0.6. The production of Mn-SOD Dr was induced with 1 mM isopropyl -d-thiogalactopyranoside (IPTG) and cell growth continued for $16 h at 295 K. The cells were then harvested by centrifugation at 4500g for 20 min at 277 K. The pellet was resuspended in 10 ml of an ice-cold lysis buffer consisting of 100 mM Tris-HCl pH 7.5, 150 mM NaCl and 10 mM imidazole supplemented with 1 mM MgCl 2 , 10 mg ml À1 DNAseI, 100 mg ml À1 lysozyme and a Complete Mini EDTA-free cocktail of antiproteases (Roche). The cells were then sonicated on ice using five 30 s pulses and the cell debris was removed by centrifugation at 17 000g for 90 min at 277 K.
The resulting supernatant was applied onto a Hi-Trap column (Amersham Biosciences) previously loaded with 0.1 M nickel sulfate and pre-equilibrated with a buffer consisting of 20 mM Tris-HCl pH 7.5, 500 mM NaCl, 2 mM imidazole and 2 mM MnCl 2 (buffer A). Mn-SOD Dr was eluted using a 50 ml linear gradient from buffer A to a buffer consisting of 20 mM Tris-HCl pH 7.5, 500 mM NaCl, 500 mM imidazole and 2 mM MnCl 2 using a flow rate of 1 ml min À1 .
Mn-SOD Dr eluted at an imidazole concentration of $250 mM. The fractions containing Mn-SOD Dr were then pooled and dialysed against a buffer comprising 10 mM Tris-HCl pH 7.5 and 1 mM EGTA (buffer B) and applied onto a 1 ml Mono-Q ion-exchange chromatography column (Amersham Biosciences) previously equilibrated with buffer B. Mn-SOD Dr was eluted using a 30 ml linear gradient from buffer B to a buffer consisting of 20 mM Tris-HCl pH 7.5, 1 mM EGTA and 1 M NaCl. SDS-PAGE analysis (data not shown) confirmed that pure, tagged, recombinant Mn-SOD Dr of the correct molecular weight (231 amino acids, $26 kDa) had been obtained a with high degree of purity using the above protocol. For crystallization trials, protein stock solutions were prepared by pooling fractions containing the pure protein, dialysing them against a buffer consisting of 10 mM Tris-HCl pH 7.5, 20 mM NaCl and 1 mM MnCl 2 and then concentrating to 10 mg ml À1 . The stock solution used in the activity measurements described in x2.2 was prepared as described above except that the protein concentration was 20 mg ml À1 .
Measurement of DEIRA Mn-SOD activity
The specific activity of Mn-SOD Dr was determined using an SOD Assay Kit-WST (Dojindo Molecular Technologies Inc., Maryland, USA) according to the manufacturer's protocol (Dojindo Molecular Technologies Inc., 2005) . WST-1 [2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt] is a soluble tetrazolium salt that produces a water-soluble formazan dye upon reduction with a superoxide anion. The rate of the reduction with O À 2 is linearly related to xanthine oxidase activity and is inhibited by SOD. Thus, the IC 50 (50% inhibition activity of SOD or SOD-like materials) can be determined by a colorimetric method. Standard solutions of Mn-SOD Ec (Sigma-Aldrich Inc., MO, USA) were prepared at concentrations of 200, 100, 50, 20, 10, 5, 1, 0.1, 0.05, 0.01 and 0.001 U ml À1 in the SOD Assay Kit-WST dilution buffer and Mn-SOD Dr (20 mg ml À1 ) obtained as described above was diluted 100, 500 and 1000 times in the same buffer. 20 ml each of the solutions of Mn-SOD Ec , Mn-SOD Dr and three blank solutions (water blank 1, sample blank 2 and water blank 3) were transferred in triplets into microplate wells and 200 ml WST working solution and 20 ml enzyme working solution supplied by the manufacturer was added (except for blank 2 and 3, to which 20 ml dilution buffer was added). The reactions were incubated at 310 K for 20 min and absorbance was read at 405 nm in a V max microplate reader (Molecular Devices Corp., CA, USA). The SOD activity (inhibition rate) was calculated using the equation and plotted onto an inhibition curve. The amount of Mn-SOD Dr in the samples was determined from the curve in U ml À1 and used for calculations of the specific activity.
2.3. Crystallization, data collection and processing, structure solution and refinement Crystals of Mn-SOD Dr appeared from several hanging-drop trials in which 2 ml protein stock solution and 2 ml reservoir solution were equilibrated at 293 K against 1 ml reservoir solution. Those most amenable to the collection of good-quality X-ray diffraction data were obtained using reservoir solutions consisting of either 10 mM Tris-HCl pH 8.5, 20 mM MnCl 2 , 30% PEG 4000 (crystal form I) or 10 mM Tris-HCl pH 8.5, 10% PEG 8000, 14% PEG 1500 and 10 mM MnCl 2 (crystal form II). In both cases further cryoprotection of the crystals was not required and both were flash-frozen in a stream of gaseous nitrogen prior to data collection.
X-ray diffraction data from a single crystal of form I (Table 1) were collected at 100 K and = 0.933 Å on beamline ID14-EH1 of the ESRF, with the intensity data being indexed and integrated using the program MOSFLM, scaled and merged using SCALA and structure factors obtained using the program TRUNCATE. The indexing, integration, scaling and merging procedures clearly showed the crystals to be monoclinic, with unit-cell parameters a = 44.28, b = 83.21, c = 59.52 Å , = 110.18 ; examination of systematic absences in the intensity data indicated the space group to be P2 1 . A calculated Matthews coefficient of 2.2 Å 3 Da À1 and a theoretical solvent content of $43% are consistent with the asymmetric unit containing two Mn-SOD monomers.
X-ray diffraction data from a single crystal of form II (Table 1) were also collected at 100 K on beamline ID14-EH1, with the intensity data being treated in the same way as for form I. The crystals of form II are also monoclinic, with space group P2 1 and unit-cell parameters a = 43.57, b = 87.10, c = 116.42 Å , = 92.1 . For this crystal form a calculated Matthews coefficient of 2.3 Å 3 Da À1 and a theoretical solvent content of $47% are consistent with the asymmetric unit containing four Mn-SOD monomers.
Structure solution for crystal form I was carried out using the molecular-replacement (MR) technique as implemented in the program CNS (Brü nger et al., 1998 ). The search model was a monomer from the crystal structure of Mn-SOD Ec (PDB code 1vew; Edwards et al., 1998) stripped of all solvent molecules and metal ions which was modified such that the residues in two loop regions (44-46, 92-95; Mn-SOD Ec numbering) were removed and amino-acid residues larger in the sequence of Mn-SOD Dr than in that of Mn-SOD Ec (see Fig. 1 for the sequence alignment) were truncated to alanine. The MR protocol used data in the resolution range 20.0-4.0 Å , resulted in Patterson and packing correlation coefficients of 58.0 and 61.0%, respectively, and confirmed that form I contains two molecules arranged as a homodimer in the asymmetric unit. The MR solution was then subjected to a round of rigid-body refinement using data in the range 40.0-3.5 Å , yielding R = 34.3%, R free = 34.6%. An initial round of simulated-annealing-based model refinement was then carried out using CNS. This was followed by a refinement protocol using the program REFMAC5 (Winn et al., 2001 and references therein) interspersed with rounds of manual rebuilding using the program QUANTA (Accelrys Inc.; http://www.accelrys.com), during which the model of Mn-SOD Dr was improved and water molecules and Mn 3+ ions included.
Structure solution for crystal form II was also carried out using the MR technique, this time using the program AMoRe (Navaza, 1994). The search model was a monomer from the partially refined crystal form I structure of Mn-SOD Dr stripped of all solvent molecules and Mn 3+ ions. The MR protocol was carried out using data in the resolution range 15-3 Å , resulted in R = 35.2%, CC (Fobs, Fcalc) = 66.8% and clearly showed that form II contains four molecules arranged in two homodimers in the asymmetric unit. Model refinement was carried out using the program REFMAC5 interspersed with rounds of manual rebuilding using the program O (Jones et al., 1991) , during which the model was improved and water molecules and Mn 3+ ions were included. Details concerning diffraction data quality and showing the results of both refinement protocols are shown in Table 1 
Results and discussion
The composition of the final refined models for both crystal forms of Mn-SOD Dr are summarized in Table 1 . Briefly, crystal form I contains a homodimer in the asymmetric unit and the model consists of aminoacid residues A1-A43, A45-A89, A96-A210, B1-B90, B96-B210, two Mn 3+ ions and 366 solvent molecules. Crystal form II contains two homodimers in the asymmetric unit, with the final refined model consisting of residues A1-A92, A99-A210, B1-B43, B46-B91, B97- 0.0/0.0 0.0/0.0/0.6 (Cys96)/0.0 † For crystal form II the completeness in the resolution range 41.2-2.25 Å is 95.4%. ‡ Some side chains are disordered and are not included in the final model. For crystal form I residues A126, B66 and B120 are truncated at C , residues A40, A104, B40 and B43 are truncated at C and residues A142 and B142 are truncated at C . For crystal form II residues A142, A210, A53, A102, B40, B46, B53, B105, C91, C210, D139 and D158 are truncated at C , while residues B23 and C94 are truncated at S and C , respectively.
B210, C1-C91, C94-C210, D1-D91, D96-D210, four Mn 3+ ions and 567 solvent molecules. For both crystal forms the residue-numbering scheme refers to the sequence of DR1279 as deposited in the UniProtKB/Swiss-Prot database (http://www.expasy.org; primary accession No. Q9RUV2) and the final models described ignore residues from the purification tag modelled into electron density.
The three-dimensional structures of all the monomers found in both crystal forms are extremely similar, yielding r.m.s. deviations in C positions of 0.26, 0.30, 0.30, 0.31 and 0.32 Å when monomer A of crystal form I is superimposed on monomer B of crystal form I and monomers A, B, C and D of crystal form II, respectively.
During the course of this work, coordinates for an independently determined structure of DR1279 in crystal form II described above were deposited in the Protein Data Bank (PDB code 1y67; S. Chan, S. Tanaka, M. R. Sawaya & L. J. Perry, unpublished work). Superposing the structure of monomer A in crystals forms I and II as determined in this work with the four SOD monomers found the asymmetric unit of form II as determined by Chan and coworkers results in r.m.s. deviations in C positions of 0.26, 0.28, 0.38 and 0.32 Å (crystal form I) and 0.35, 0.25, 0.26 and 0.32 Å (crystal form II), respectively. Similarly, superimposing the AB homodimer in crystal forms I and II with the AB homodimer found in the structure deposited in the PDB results in r.m.s. deviations in C positions of 0.30 and 0.48 Å , respectively. Thus, the structures determined in this work and that determined by Chan and coworkers are essentially identical. However, it is intriguing to note that in the structure of DR1279 as determined by Chan and coworkers the metal ions bound to the protein are assigned as Fe 3+ rather than Mn 3+ . This is despite the fact that DR1279 is clearly annotated as an Mn-SOD in the UniProtKB/ Swiss-Prot database (see http://ca.expasy.org/ uniprot/Q9RUV2) and that in the sequence of DR1279 the residues proposed as being the most likely candidates as markers for distinguishing between Mn-SODs and Fe-SODs (Parker & Blake, 1988) clearly indicate DR1279 to be a Mn-SOD. Moreover, the wavelength (1.1 Å ) at which Chan and coworkers collected diffraction data for their structure solution does not allow one to distinguish between Fe 3+ and Mn 3+ . Nevertheless, in all cases the threedimensional structures of the Mn-SOD Dr monomers ( Fig. 2a ) are very similar to those reported in crystal structures of Mn-SOD Ec (Edwards et al., 1998 (Edwards et al., , 2001 Borgstahl et al., 2000) . Similarly, the structures of the physiologically relevant Mn-SOD Dr dimers (Fig. 2b) in the crystal structures reported here and by Chan and coworkers are essentially isostructural to those found for Mn-SOD Ec and other Mn-SODs. The r.m.s. deviations between around 400 common C positions from superpositions of the Mn-SOD Ec dimer and those found in crystal forms I and II of Mn-SOD Dr average around 0.75 Å .
The metal-ion coordination sphere, which is absolutely conserved in all Mn-SODs, consists of the side chains of the amino-acid residues His26, His80, Asp172 and His176, which along with a conserved water molecule are arranged in a trigonal bipyramidal geometry around the metal ion. access to the catalytic centre being guarded by several so-called 'gateway residues' (see Fig. 1 ; Edwards et al., 2001) . These residues are very highly conserved throughout Mn-SOD sequences. In Mn-SOD Dr these residues are His30, Tyr34, Gln151, Glu175 0 and Tyr179 0 (the 0 denotes that the residues are from the second monomer of the homodimer). Both these amino-acid residues and their structural arrangement are absolutely conserved between Mn-SOD Dr and Mn-SOD Ec .
Based upon the above comparison of the crystal structures of Mn-SOD Dr and Mn-SOD Ec , one can infer that their tertiary and quaternary structures are extremely similar and that the geometric and electrostatic properties of their catalytic centres are essentially identical. One might thus expect the activities of the two enzymes to be similar. However, in our hands (see x2.2), the measured activities of 1250 and 2740 U mg À1 for Mn-SOD Dr and Mn-SOD Ec indicate that the activity of Mn-SOD Dr is rather lower than that of its E. coli counterpart. Thus, the importance of Mn-SOD to the radiation resistance of DEIRA cannot be attributed to a higher activity of Mn-SOD Dr with respect to that of Mn-SOD Ec .
It has been shown that in E. coli Mn-SOD preferentially protects DNA from damage caused by the presence of ROS (Hopkin et al., 1992) . This, coupled with later discovery that E. coli Mn-SOD binds in a non-specific manner to DNA (Steinman et al., 1994) , led to the suggestion that in E. coli Mn-SOD acts as a 'tethered antioxidant' which by binding to DNA concentrates its activity on scavenging superoxide radicals found close to DNA, thus preferentially ensuring its protection. The determination of the crystal structure of Mn-SOD Ec allowed the construction of a plausible model of how Mn-SODs and DNA might interact (see Figs. 6 and 7 of Edwards et al., 1998) . In this model, DNA binds in a positively charged semicircular groove formed at the monomer-monomer interface of the Mn-SOD homodimer, with amino-acid side chains from two loops on the surface of each monomer (formed by residues 61-67 and 152-158, respectively) providing anchoring points for the DNA. Both the positive charge of the hemihedral groove and the amino acids in the DNA-anchoring loops are highly conserved between the structures of Mn-SOD Dr and Mn-SOD Ec . Therefore, it may well be that in DEIRA Mn-SOD plays the same role as it is proposed to play in E. coli.
As mentioned in x1, the only really significant difference between the amino-acid sequences of Mn-SOD Dr and Mn-SOD Ec is a sixresidue insert of sequence QGQNGA between residues 91 and 92 (E. coli numbering; Fig. 1 ). In the crystal structures of Mn-SOD Dr , this region of the sequence forms part of a solvent-accessible loop joining the helices 1 and 2. However, in the structures reported here and in that deposited in the PDB by Chan and coworkers, the residues making up the insert are disordered (Fig. 2) and are in a region of structure that is unlikely to affect either the active site or (potential) DNA binding by Mn-SOD Dr . However, they clearly point away from the body of the Mn-SOD Dr structure. Thus, although there is currently no evidence to support such a hypothesis, it may be that the residues in this insert provide a means by which Mn-SOD Dr can interact with other proteins and thus act as a 'tethered antioxidant' protecting not only DNA but also proteins that are crucial to the radiation resistance of DEIRA.
